233 related articles for article (PubMed ID: 36548768)
1. Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jiang YH; Jhang JF; Chang WC; Kuo HC
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548768
[TBL] [Abstract][Full Text] [Related]
2. Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jhang JF; Kuo HC
Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393152
[TBL] [Abstract][Full Text] [Related]
3. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
5. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Wang HJ; Yu WR; Ong HL; Kuo HC
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
7. Using Botulinum Toxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome-Possible Pathomechanisms and Practical Issues.
Jhang JF
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31689912
[TBL] [Abstract][Full Text] [Related]
8. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
9. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
10. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
Chung SD; Kuo YC; Kuo HC
Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
[TBL] [Abstract][Full Text] [Related]
11. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
Kuo YC; Kuo HC
Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial.
Jiang YH; Jhang JF; Lee CL; Kuo HC
Neurourol Urodyn; 2018 Apr; 37(4):1467-1473. PubMed ID: 29331031
[TBL] [Abstract][Full Text] [Related]
13. The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis.
Jiang YH; Jhang JF; Kuo HC
Tzu Chi Med J; 2023; 35(1):31-37. PubMed ID: 36866354
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
Lee CL; Kuo HC
Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis.
Giannantoni A; Gubbiotti M; Bini V
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31480323
[TBL] [Abstract][Full Text] [Related]
16. Preliminary Exploration of a New Therapy for Interstitial Cystitis/Bladder Pain Syndrome: Botulinum Toxin A Combined with Sapylin.
Li W; Zheng Z; Ma K; Zhang C; Li K; Tayier P; Yao Y
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548729
[TBL] [Abstract][Full Text] [Related]
17. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
Dellis A; Papatsoris AG
Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
[TBL] [Abstract][Full Text] [Related]
18. Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders.
Jhang JF; Kuo HC
Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069951
[TBL] [Abstract][Full Text] [Related]
19. Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders.
Hung FC; Kuo HC
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548734
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis.
Chiu B; Tai HC; Chung SD; Birder LA
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27376330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]